Hopewell Therapeutics is a Synthetic Lipid-based drug delivery company for gene therapy and gene editing.
Hopewell Therapeutics is a Synthetic Lipid-based drug delivery company for gene therapy and gene editing. It is intended to provide and services in the field of novel drug delivery systems.The company was founded in 2018 and is based in Boston, Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 2, 2022 | Series Unknown | $7.10M | — | — | — | Detail |
Oct 8, 2021 | Series Unknown | $8M | — | — | — | Detail |
Sep 1, 2021 | Seed | — | 1 | Massachusetts Avenue Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Massachusetts Avenue Capital | Yes | Seed |